Huebschmann, Amy G.
Huxley, Rachel R.
Kohrt, Wendy M.
Zeitler, Philip
Regensteiner, Judith G.
Reusch, Jane E. B.
Funding for this research was provided by:
Office of Veterans Affairs (CX001532)
Center for Scientific Review (HD057022)
Article History
Received: 20 April 2019
Accepted: 29 May 2019
First Online: 27 August 2019
Duality of interest
: AGH, JEBR and JGR report recently completed grant funding from Merck, for an investigator-initiated trial that is outside the scope of the submitted work. JEBR reports a consulting agreement with Oramed. PZ reports unrelated consulting agreements with the following companies: Merck, Daichii-Sankyo, Eli Lilly, Boehringer-Ingelheim, Takeda and Tolmar. All other authors (RRH, WMK) declare no competing interests.
Free to read: This content has been made available to all.